Marc A Shuman

Author PubWeight™ 15.01^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment.	Blood	2002	2.28
2	Protein biomarker identification in the CSF of patients with CNS lymphoma.	J Clin Oncol	2007	2.07
3	Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics.	Genes Dev	2012	1.64
4	Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma.	Clin Cancer Res	2013	1.42
5	Differential gene expression in central nervous system lymphoma.	Blood	2009	1.12
6	Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.	Clin Cancer Res	2012	1.07
7	Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.	Blood	2012	1.07
8	Quinine/quinidine-induced thrombocytopenia: a great imitator.	Arch Intern Med	2004	1.00
9	Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.	Biol Chem	2003	0.98
10	Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model.	Clin Cancer Res	2009	0.98
11	Time-resolved single-step protease activity quantification using nanoplasmonic resonator sensors.	ACS Nano	2010	0.90
12	Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.	J Clin Invest	2016	0.75